Driving Factors for Minimally Invasive Surgery

marketngage21 曰く、

The growing global geriatric population, combined with the rising prevalence of arthritis, cancer, and cardiovascular disease, is driving the demand for these surgeries, which are associated with fewer risks and minimal procedural trauma. The most recent technological advancements have included robotic assisted minimally invasive surgery, which allows for precise control over the surgery. This has resulted in higher success rates by ensuring greater accuracy, repeatability, control, and efficiency of these procedures, bolstering market growth.

This surgery has excellent medical characteristics such as fewer cuts, smaller incisions, less pain, shorter recovery times, and significant cost savings. Smaller incisions, reduced post-operative pain, and quick recovery influenced surgeons to make it their first choice over open surgeries in their own clinics. As a result, the growing number of physician-owned ambulatory surgical centres (ASCs) is fuelling minimally invasive surgery market growth.

Investments in the minimally invasive surgery market have been shaped by the increasing adoption of robotic-assisted surgeries and advancements in image guidance systems. This is due to low regulatory barriers, improvements in healthcare infrastructure, an increasing patient population, and rising healthcare expenditure.
As the demand for automation in hospital workflows has increased, surgeons are adopting robotic assisted surgeries to streamline operations and thus reduce labour burden. Numerous healthcare companies, including Hansen Medical (Magellan Robotic System), Diligent Robotics (Moxi), and Medrobotics (Flex® Robotic System), have introduced advanced robotic systems.

Manufacturers have introduced technologically advanced products such as narrow-band imaging endoscopes and HD cameras, which are creating a positive outlook for the industry globally. Patients, surgeons, and hospitals have benefited from and are increasingly adopting high-precision, minimally invasive robotic surgery (MIRS), resulting in a double-digit annual growth rate over the last five years. Currently, the FDA has approved the use of robotic surgery in more than 50 procedures in fields such as weight loss surgery, cardiothoracic surgery, and gynaecology, which is expected to drive demand for robot assisted MIS in the coming years.

According to the research study by MarketNgage, the trusted platform for Healthcare market research report subscription, United States is a market leader in North America for minimally invasive surgeries, and it is expected to maintain this position throughout the forecast period. The large share of the US market can be attributed to the availability of funding for R&D in surgical robots, as well as the growing adoption of surgical robots for paediatric surgeries, in conjunction with the country's rising prevalence of chronic disorders.

To Get Your Hands on Full Coverage of Healthcare Industry –
SignUp for FREE market research report subscription and access complete Minimally Invasive Surgery Market Report with MarketNgage

情報元へのリンク